Açıklama

Change from baseline in IBS symptom severity scores (IBS-SSS) across treatment groups, indicating that both probiotic strains were associated with greater symptom relief compared to placebo.

Figure 3

Chart

Source Paper

Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.

Nutrients (2020)

PMID: 32019158

DOI: 10.3390/nu12020363

Cite This Figure

![Figure 3: Change from baseline in IBS symptom severity scores (IBS-SSS) across treatment groups, indicating that both probiotic strains were associated with greater symptom relief compared to placebo.]()

> Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." *Nutrients*, 2020. PMID: [32019158](https://pubmed.ncbi.nlm.nih.gov/32019158/)

<figure>
  <img src="" alt="Change from baseline in IBS symptom severity scores (IBS-SSS) across treatment groups, indicating that both probiotic strains were associated with greater symptom relief compared to placebo." />
  <figcaption>Figure 3. Change from baseline in IBS symptom severity scores (IBS-SSS) across treatment groups, indicating that both probiotic strains were associated with greater symptom relief compared to placebo.<br>  Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32019158/">32019158</a></figcaption>
</figure>

İlgili Kanıtlar

Lactobacillus acidophilus için Irritable Bowel Syndrome (IBS)

Derece B · 3 çalışma